Incorporation of these binding-site data with differentially expressed genes identified 41 targets of TCF7L1-mediated repression, including GAS1. In rescue experiments, we demonstrated that GAS1 is an effector of TCF7L1-mediated CRC migration and invasion. Here, GAS1 is linked to colorectal carcinoma.